Detection of LINE-1s hypomethylation in oral rinses of oral squamous cell carcinoma patients

Oral Oncology

Volumn 45, Issue 2, 2009, Pages 184-191

  Subbalekha, Keskanya ^a,c   Pimkhaokham, Atiphan ^a   Pavasant, Prasit ^a   Chindavijak, Somjin ^b   Phokaew, Chureerat ^c   Shuangshoti, Shanop ^a   Matangkasombut, Oranart ^a   Mutirangura, Apiwat ^c  

^a CHULALONGKORN UNIVERSITY   (Thailand)

^b NATIONAL CANCER INSTITUTE   (Thailand)

^c THAMMASAT UNIVERSITY   (Thailand)

Author keywords

Hypomethylation; LINE 1; Oral rinses; Oral squamous cell carcinoma

Indexed keywords

ALCOHOL; BISULFITE; MOUTHWASH;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; BETEL NUT; CANCER PATIENT; CONTROLLED STUDY; FEMALE; HISTOLOGY; HISTORY; HUMAN; HUMAN CELL; HUMAN TISSUE; LONG INTERSPERSED NUCLEAR ELEMENT 1S; LONG INTERSPERSED REPEAT; MALE; MASTICATION; METHYLATION; MOUTH CARCINOMA; NON INVASIVE PROCEDURE; NUCLEOTIDE SEQUENCE; ORAL SQUAMOUS CELL CARCINOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION MAPPING; SMOKING; SQUAMOUS CELL CARCINOMA; VOLUNTEER;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; DNA METHYLATION; FEMALE; HUMANS; LONG INTERSPERSED NUCLEOTIDE ELEMENTS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; POLYMERASE CHAIN REACTION; YOUNG ADULT;

EID: 58549101871     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2008.05.002     Document Type: Article

References (59)

1. Conway D.I., Stockton D.L., Warnakulasuriya K.A., Ogden G., and Macpherson L.M. Incidence of oral and oropharyngeal cancer in United Kingdom (1990-1999) - recent trends and regional variation. Oral Oncol 42 6 (2006) 586-592
2. Schantz S.P., and Yu G.P. Head and neck cancer incidence trends in young Americans, 1973-1997, with a special analysis for tongue cancer. Arch Otolaryngol Head Neck Surg 128 3 (2002) 268-274
3. Parkin D.M., Bray F., Ferlay J., and Pisani P. Global cancer statistics 2002. CA Cancer J Clin 55 2 (2005) 74-108
4. Jemal A., Murray T., Ward E., Samuels A., Tiwari R.C., Ghafoor A., et al. Cancer statistics, 2005. CA Cancer J Clin 55 1 (2005) 10-30
5. Silverman Jr. S. Demographics and occurrence of oral and pharyngeal cancers. The outcomes, the trends, the challenge. J Am Dent Assoc 132 Suppl (2001) 7S-11S
6. Sargeran K., Murtomaa H., Safavi S.M., Vehkalahti M.M., and Teronen O. Survival after diagnosis of cancer of the oral cavity. Br J Oral Maxillofac Surg 46 3 (2008) 187-191
7. Lam L., Logan R.M., Luke C., and Rees G.L. Retrospective study of survival and treatment pattern in a cohort of patients with oral and oropharyngeal tongue cancers from 1987 to 2004. Oral Oncol 43 2 (2007) 150-158
8. Epstein J.B., Sciubba J., Silverman Jr. S., and Sroussi H.Y. Utility of toluidine blue in oral premalignant lesions and squamous cell carcinoma: continuing research and implications for clinical practice. Head Neck 29 10 (2007) 948-958
9. Zhang L., Williams M., Poh C.F., Laronde D., Epstein J.B., Durham S., et al. Toluidine blue staining identifies high-risk primary oral premalignant lesions with poor outcome. Cancer Res 65 17 (2005) 8017-8021
10. Epstein J.B., Oakley C., Millner A., Emerton S., van der Meij E., and Le N. The utility of toluidine blue application as a diagnostic aid in patients previously treated for upper oropharyngeal carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 83 5 (1997) 537-547
11. Chen Y.W., Lin J.S., Fong J.H., Wang I.K., Chou S.J., Wu C.H., et al. Use of methylene blue as a diagnostic aid in early detection of oral cancer and precancerous lesions. Br J Oral Maxillofac Surg 45 7 (2007) 590-591
12. Epstein J.B., Feldman R., Dolor R.J., and Porter S.R. The utility of tolonium chloride rinse in the diagnosis of recurrent or second primary cancers in patients with prior upper aerodigestive tract cancer. Head Neck 25 11 (2003) 911-921
13. Ram S., and Siar C.H. Chemiluminescence as a diagnostic aid in the detection of oral cancer and potentially malignant epithelial lesions. Int J Oral Maxillofac Surg 34 5 (2005) 521-527
14. Poate T.W., Buchanan J.A., Hodgson T.A., Speight P.M., Barrett A.W., Moles D.R., et al. An audit of the efficacy of the oral brush biopsy technique in a specialist Oral Medicine unit. Oral Oncol 40 8 (2004) 829-834
15. Spafford M.F., Koch W.M., Reed A.L., Califano J.A., Xu L.H., Eisenberger C.F., et al. Detection of head and neck squamous cell carcinoma among exfoliated oral mucosal cells by microsatellite analysis. Clin Cancer Res 7 3 (2001) 607-612
16. Svirsky J.A., Burns J.C., Carpenter W.M., Cohen D.M., Bhattacharyya I., Fantasia J.E., et al. Comparison of computer-assisted brush biopsy results with follow up scalpel biopsy and histology. Gen Dent 50 6 (2002) 500-503
17. Acha A., Ruesga M.T., Rodriguez M.J., Martinez de Pancorbo M.A., and Aguirre J.M. Applications of the oral scraped (exfoliative) cytology in oral cancer and precancer. Med Oral Patol Oral Cir Bucal 10 2 (2005) 95-102
18. Shpitzer T., Bahar G., Feinmesser R., and Nagler R.M. A comprehensive salivary analysis for oral cancer diagnosis. J Cancer Res Clin Oncol 133 9 (2007) 613-617
19. Bahar G., Feinmesser R., Shpitzer T., Popovtzer A., and Nagler R.M. Salivary analysis in oral cancer patients: DNA and protein oxidation, reactive nitrogen species, and antioxidant profile. Cancer 109 1 (2007) 54-59
20. Nagler R., Bahar G., Shpitzer T., and Feinmesser R. Concomitant analysis of salivary tumor markers - a new diagnostic tool for oral cancer. Clin Cancer Res 12 13 (2006) 3979-3984
21. St John M.A., Li Y., Zhou X., Denny P., Ho C.M., Montemagno C., et al. Interleukin 6 and interleukin 8 as potential biomarkers for oral cavity and oropharyngeal squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 130 8 (2004) 929-935
22. Franzmann E.J., Reategui E.P., Pedroso F., Pernas F.G., Karakullukcu B.M., Carraway K.L., et al. Soluble CD44 is a potential marker for the early detection of head and neck cancer. Cancer Epidemiol Biomarkers Prev 16 7 (2007) 1348-1355
23. Righini C.A., de Fraipont F., Timsit J.F., Faure C., Brambilla E., Reyt E., et al. Tumor-specific methylation in saliva: a promising biomarker for early detection of head and neck cancer recurrence. Clin Cancer Res 13 4 (2007) 1179-1185
24. Piyathilake C.J., Frost A.R., Bell W.C., Oelschlager D., Weiss H., Johanning G.L., et al. Altered global methylation of DNA: an epigenetic difference in susceptibility for lung cancer is associated with its progression. Hum Pathol 32 8 (2001) 856-862
25. Guerrero-Preston R., Santella R.M., Blanco A., Desai M., Berdasco M., and Fraga M. Global DNA hypomethylation in liver cancer cases and controls: a phase I preclinical biomarker development study. Epigenetics 2 4 (2007) 223-226
26. de Capoa A., Musolino A., Della Rosa S., Caiafa P., Mariani L., Del Nonno F., et al. DNA demethylation is directly related to tumour progression: evidence in normal, pre-malignant and malignant cells from uterine cervix samples. Oncol Rep 10 3 (2003) 545-549
27. Hoffmann M.J., and Schulz W.A. Causes and consequences of DNA hypomethylation in human cancer. Biochem Cell Biol 83 3 (2005) 296-321
28. Shaw R.J., Hall G.L., Lowe D., Bowers N.L., Liloglou T., Field J.K., et al. CpG island methylation phenotype (CIMP) in oral cancer: associated with a marked inflammatory response and less aggressive tumour biology. Oral Oncol 43 9 (2007) 878-886
29. Ha P.K., and Califano J.A. Promoter methylation and inactivation of tumour-suppressor genes in oral squamous-cell carcinoma. Lancet Oncol 7 1 (2006) 77-82
30. Shaw R. The epigenetics of oral cancer. Int J Oral Maxillofac Surg 35 2 (2006) 101-108
31. Nakagawa T., Pimkhaokham A., Suzuki E., Omura K., Inazawa J., and Imoto I. Genetic or epigenetic silencing of low density lipoprotein receptor-related protein 1B expression in oral squamous cell carcinoma. Cancer Sci 97 10 (2006) 1070-1074
32. Feinberg A.P., and Tycko B. The history of cancer epigenetics. Nat Rev Cancer 4 2 (2004) 143-153
33. Ostertag E.M., and Kazazian Jr. H.H. Biology of mammalian L1 retrotransposons. Annu Rev Genet 35 (2001) 501-538
34. Chalitchagorn K., Shuangshoti S., Hourpai N., Kongruttanachok N., Tangkijvanich P., Thong-ngam D., et al. Distinctive pattern of LINE-1 methylation level in normal tissues and the association with carcinogenesis. Oncogene 23 54 (2004) 8841-8846
35. Choi I.S., Estecio M.R., Nagano Y., Kim do H., White J.A., Yao J.C., et al. Hypomethylation of LINE-1 and Alu in well-differentiated neuroendocrine tumors (pancreatic endocrine tumors and carcinoid tumors). Mod Pathol 20 7 (2007) 802-810
36. Takai D., Yagi Y., Habib N., Sugimura T., and Ushijima T. Hypomethylation of LINE1 retrotransposon in human hepatocellular carcinomas, but not in surrounding liver cirrhosis. Jpn J Clin Oncol 30 7 (2000) 306-309
37. Suter C.M., Martin D.I., and Ward R.L. Hypomethylation of L1 retrotransposons in colorectal cancer and adjacent normal tissue. Int J Colorectal Dis 19 2 (2004) 95-101
38. Santourlidis S., Florl A., Ackermann R., Wirtz H.C., and Schulz W.A. High frequency of alterations in DNA methylation in adenocarcinoma of the prostate. Prostate 39 3 (1999) 166-174
39. Florl A.R., Lower R., Schmitz-Drager B.J., and Schulz W.A. DNA methylation and expression of LINE-1 and HERV-K provirus sequences in urothelial and renal cell carcinomas. Br J Cancer 80 9 (1999) 1312-1321
40. Jurgens B., Schmitz-Drager B.J., and Schulz W.A. Hypomethylation of L1 LINE sequences prevailing in human urothelial carcinoma. Cancer Res 56 24 (1996) 5698-5703
41. Kazazian Jr. H.H., and Moran J.V. The impact of L1 retrotransposons on the human genome. Nat Genet 19 1 (1998) 19-24
42. Smith I.M., Mydlarz W.K., Mithani S.K., and Califano J.A. DNA global hypomethylation in squamous cell head and neck cancer associated with smoking, alcohol consumption and stage. Int J Cancer 121 8 (2007) 1724-1728
43. Hsiung D.T., Marsit C.J., Houseman E.A., Eddy K., Furniss C.S., McClean M.D., et al. Global DNA methylation level in whole blood as a biomarker in head and neck squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 16 1 (2007) 108-114
44. Pattamadilok J., Huapai N., Rattanatanyong P., Vasurattana A., Triratanachat S., Tresukosol D., et al. LINE-1 hypomethylation level as a potential prognostic factor for epithelial ovarian cancer. Int J Gynecol Cancer (2007)
45. Shuangshoti S., Hourpai N., Pumsuk U., and Mutirangura A. Line-1 hypomethylation in multistage carcinogenesis of the uterine cervix. Asian Pac J Cancer Prev 8 2 (2007) 307-309
46. Tangkijvanich P., Hourpai N., Rattanatanyong P., Wisedopas N., Mahachai V., and Mutirangura A. Serum LINE-1 hypomethylation as a potential prognostic marker for hepatocellular carcinoma. Clin Chim Acta 379 1-2 (2007) 127-133
47. Mutirangura A. Quantitative PCR analysis for methylation level of genome: clinical implications in cancer. Asian Biomed 1 2 (2007) 121-128
48. Funk G.F., Karnell L.H., Robinson R.A., Zhen W.K., Trask D.K., and Hoffman H.T. Presentation, treatment, and outcome of oral cavity cancer: a National Cancer Data Base report. Head Neck 24 2 (2002) 165-180
49. Xiong Z., and Laird P.W. COBRA: a sensitive and quantitative DNA methylation assay. Nucleic Acids Res 25 12 (1997) 2532-2534
50. El-Naggar A.K., Mao L., Staerkel G., Coombes M.M., Tucker S.L., Luna M.A., et al. Genetic heterogeneity in saliva from patients with oral squamous carcinomas: implications in molecular diagnosis and screening. J Mol Diagn 3 4 (2001) 164-170
51. Rosas S.L., Koch W., da Costa Carvalho M.G., Wu L., Califano J., Westra W., et al. Promoter hypermethylation patterns of p16, O6-methylguanine-DNA-methyltransferase, and death-associated protein kinase in tumors and saliva of head and neck cancer patients. Cancer Res 61 3 (2001) 939-942
52. Califano J., Ahrendt S.A., Meininger G., Westra W.H., Koch W.M., and Sidransky D. Detection of telomerase activity in oral rinses from head and neck squamous cell carcinoma patients. Cancer Res 56 24 (1996) 5720-5722
53. Jiang W.W., Masayesva B., Zahurak M., Carvalho A.L., Rosenbaum E., Mambo E., et al. Increased mitochondrial DNA content in saliva associated with head and neck cancer. Clin Cancer Res 11 7 (2005) 2486-2491
54. Carvalho A.L., Jeronimo C., Kim M.M., Henrique R., Zhang Z., Hoque M.O., et al. Evaluation of promoter hypermethylation detection in body fluids as a screening/diagnosis tool for head and neck squamous cell carcinoma. Clin Cancer Res 14 1 (2008) 97-107
55. Nunes D.N., Kowalski L.P., and Simpson A.J. Detection of oral and oropharyngeal cancer by microsatellite analysis in mouth washes and lesion brushings. Oral Oncol 36 6 (2000) 525-528
56. Mager D.L., Haffajee A.D., Devlin P.M., Norris C.M., Posner M.R., and Goodson J.M. The salivary microbiota as a diagnostic indicator of oral cancer: a descriptive, non-randomized study of cancer-free and oral squamous cell carcinoma subjects. J Transl Med 3 1 (2005) 27
57. Zimmermann B.G., and Wong D.T. Salivary mRNA targets for cancer diagnostics. Oral Oncol (2007)
58. Li Y., St John M.A., Zhou X., Kim Y., Sinha U., Jordan R.C., et al. Salivary transcriptome diagnostics for oral cancer detection. Clin Cancer Res 10 24 (2004) 8442-8450
59. Ng I.O., Xiao L., Lam K.Y., Yuen P.W., and Ng M. Microsatellite alterations in squamous cell carcinoma of the head and neck - clustering of loss of heterozygosity in a distinct subset. Oral Oncol 36 5 (2000) 484-490